ADALIMUMAB
adalimumab 20 mg/0.2 mL injection, 2 x 0.2 mL syringes
ADALIMUMAB (15173N)
15173N
Manner of administration:Injection
Restriction
Indication: Severe active juvenile idiopathic arthritis
Treatment phase: Transitioning from non-PBS to PBS-subsidised treatment - Grandfather arrangements
Quantities & Cost
| Max qty packs | Max qty units | # of repeats | DPMQ | Max safety net | General Patient Charge |
|---|---|---|---|---|---|
| Max qty packs: 1 | Max qty units: 2 | # of repeats: 5 | DPMQ: $599.00 | Max safety net: $25.00 | General Patient Charge: $25.00 |
| Available brands | |||||
|
|
|||||